
    
      The investigators are recruiting breast cancer survivors with stage I-III or Eastern
      Cooperative Oncology Group 0-1 breast cancer to enroll in a group-delivered behavioral trial
      for insomnia. The investigators are comparing mindfulness-based therapies delivered in an
      alternative medicine context to cognitive behavioral therapy for insomnia. The intervention
      is 9 weeks, for two hours weekly.
    
  